IRIS
BARISON, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.373
EU - Europa 6.025
AS - Asia 5.767
SA - Sud America 1.271
Continente sconosciuto - Info sul continente non disponibili 171
AF - Africa 141
OC - Oceania 8
Totale 24.756
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.751
SG - Singapore 2.076
IT - Italia 1.718
RU - Federazione Russa 1.468
CN - Cina 1.409
BR - Brasile 987
GB - Regno Unito 857
VN - Vietnam 852
DE - Germania 566
CA - Canada 402
HK - Hong Kong 394
BD - Bangladesh 387
UA - Ucraina 300
FR - Francia 225
SE - Svezia 221
FI - Finlandia 156
IN - India 138
MX - Messico 122
DK - Danimarca 118
AR - Argentina 108
PL - Polonia 91
TR - Turchia 79
ES - Italia 68
NL - Olanda 65
ID - Indonesia 64
IL - Israele 62
IQ - Iraq 59
ZA - Sudafrica 57
EC - Ecuador 56
IE - Irlanda 54
JP - Giappone 47
CO - Colombia 32
UZ - Uzbekistan 27
AT - Austria 24
AE - Emirati Arabi Uniti 22
CR - Costa Rica 22
MA - Marocco 22
VE - Venezuela 22
PK - Pakistan 21
JM - Giamaica 19
PY - Paraguay 19
SA - Arabia Saudita 16
EG - Egitto 15
LT - Lituania 15
MY - Malesia 15
CL - Cile 13
JO - Giordania 12
CH - Svizzera 11
EU - Europa 11
PE - Perù 11
TN - Tunisia 11
UY - Uruguay 11
HN - Honduras 9
KE - Kenya 9
PH - Filippine 9
KZ - Kazakistan 8
TT - Trinidad e Tobago 8
AU - Australia 7
DZ - Algeria 7
GT - Guatemala 7
SV - El Salvador 7
BE - Belgio 6
DO - Repubblica Dominicana 6
GR - Grecia 6
IR - Iran 6
NI - Nicaragua 6
NP - Nepal 6
PS - Palestinian Territory 6
BH - Bahrain 5
BO - Bolivia 5
CZ - Repubblica Ceca 5
GY - Guiana 5
HR - Croazia 5
KG - Kirghizistan 5
LB - Libano 5
PT - Portogallo 5
RO - Romania 5
AZ - Azerbaigian 4
BB - Barbados 4
BY - Bielorussia 4
ET - Etiopia 4
MD - Moldavia 4
SI - Slovenia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
CG - Congo 3
HU - Ungheria 3
KW - Kuwait 3
LV - Lettonia 3
OM - Oman 3
RS - Serbia 3
SM - San Marino 3
SN - Senegal 3
TW - Taiwan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
GE - Georgia 2
GP - Guadalupe 2
Totale 24.557
Salva come PNG Salva come JPEG
Città #
Dallas 1.523
Singapore 1.079
Ashburn 812
San Jose 802
Beijing 599
Southend 444
Council Bluffs 431
Los Angeles 393
Chicago 358
Hong Kong 358
Houston 326
Chandler 314
Moscow 285
Ho Chi Minh City 260
Fairfield 252
New York 246
Ann Arbor 242
Woodbridge 226
San Mateo 200
Milan 195
Rome 165
Hanoi 161
Santa Clara 160
Wilmington 160
Seattle 153
Buffalo 150
Salt Lake City 134
Cambridge 131
Falls Church 129
The Dalles 126
São Paulo 116
Phoenix 115
Jacksonville 113
Dearborn 108
Ottawa 103
Boardman 95
Tampa 93
Lauterbourg 91
Pisa 91
Hefei 90
Helsinki 88
Portsmouth 79
Stevenage 79
Warsaw 78
Brooklyn 73
Montreal 70
Munich 69
Dong Ket 68
London 63
Elk Grove Village 62
Orem 62
Columbus 60
Mexico City 60
Lawrence 57
Beauharnois 56
Tel Aviv 53
Toronto 51
Florence 50
Denver 48
Dublin 48
Atlanta 45
Frankfurt am Main 43
Tokyo 42
Istanbul 41
San Diego 41
Chennai 39
Johannesburg 39
Naples 38
Stockholm 38
Sterling 35
Lancaster 34
Rio de Janeiro 34
Amsterdam 30
Boston 30
Poplar 30
Palermo 29
Da Nang 28
Campinas 27
Washington 27
Miami 26
Tashkent 26
Turin 26
Guayaquil 25
Bari 23
Haiphong 23
Nuremberg 23
Turku 23
Figino 22
Lappeenranta 22
Redwood City 22
Bologna 21
Central District 21
Montréal 21
San Francisco 19
Belo Horizonte 18
Charlotte 18
Detroit 18
Manchester 18
Mumbai 18
Ankara 17
Totale 14.223
Salva come PNG Salva come JPEG
Nome #
Cardiac remodelling - Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 1.599
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 710
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 466
A simple echocardiographic score to rule out cardiac amyloidosis 431
A simple echocardiographic score to rule out cardiac amyloidosis 411
Abnormal T2-STIR magnetic resonance in hypertrophic cardiomyopathy: A marker of advanced disease and electrical myocardial instability 375
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 359
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 349
Myocardial signal intensity decay after gadolinium injection: a fast and effective method for the diagnosis of cardiac amyloidosis 346
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging 342
A novel echocardiographic method for estimation of pulmonary artery wedge pressure and pulmonary vascular resistance 341
Cocaine assumption and transient myocardial edema in asymptomatic cocaine heavy-users 337
Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else? 331
Role of tissue characterization by Cardiac Magnetic Resonance in the diagnosis of constrictive pericarditis 330
Usefulness of late gadolinium enhancement MRI combined with stress imaging in predictive significant coronary stenosis in new-diagnosed left ventricular dysfunction 327
Aortic elasticity indices by magnetic resonance predict progression of ascending aorta dilation 319
Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy 315
Incremental prognostic value of myocardial fibrosis in patients with non-ischemic cardiomyopathy without congestive heart failure 313
Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study 313
A mechanistic look at sacubitril/valsartan action. Unravelling magician's secrets 312
A prognostically meaningful definition of non-dilated left ventricular cardiomyopathy 311
Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy 308
Sex-related differences in chronic heart failure 299
Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy 296
Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure 287
A Novel Homozygous Mutation of the Desmoplakin Gene With Biventricular Arrhythmogenic Cardiomyopathy 285
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 283
Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy 280
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy 279
Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling 278
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 275
Leiomyosarcoma of the inferior vena cava in a patient with Budd-Chiari syndrome 274
Update sui biomarcatori nello scompenso cardiaco. 270
The extent and location of late gadolinium enhancement predict defibrillator shock and cardiac mortality in patients with non-ischaemic dilated cardiomyopathy 270
Cardioprotection by remote ischemic conditioning: Mechanisms and clinical evidences 264
Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology 260
Cardiac magnetic resonance in patients with muscular dystrophies 260
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study 257
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 255
Role of Imaging in Cardiomyopathies 253
Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block 249
Perspectives in noninvasive imaging for chronic coronary syndromes 247
The heart after idarubicin overdose. Cardiac death in a patient with acute promyelocitic leukaemia 247
Fibrosis and mortality in patients with dilated cardiomyopathy [2] 246
Valvular heart disease in patients with cardiac amyloidosis 244
Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study" 242
Cardiovascular disease and COVID-19: les liaisons dangereuses 237
CarDiac magnEtic Resonance for prophylactic Implantable-cardioVerter defibrillAtor ThErapy in Non-Ischaemic dilated CardioMyopathy: An international Registry 235
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis 234
Deep learning to diagnose cardiac amyloidosis from cardiovascular magnetic resonance 233
Atypical progeroid syndrome and partial lipodystrophy due to LMNA gene p.R349W mutation 232
Diagnosis and management of patients with left ventricular hypertrophy: Role of multimodality cardiac imaging. A scientific statement of the Heart Failure Association of the European Society of Cardiology 231
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings 231
Molecular autopsy of sudden cardiac death in the genomics era 230
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 229
Cardiovascular magnetic resonance for the diagnosis and management of heart failure with preserved ejection fraction 226
Scared to Death: Emotional Stress Causing Fatal Myocardial Infarction With Nonobstructed Coronary Arteries in Women 225
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 216
Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction. A Study of the Collaborative Registry on CMR in STEMI 216
Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy 215
Increased extracellular volume fraction in nonischaemic dilated cardiomyopathy predicts worse outcomes independently of medical therapy 215
Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis 214
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 212
Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction 212
Colchicine for the treatment of coronary artery disease 210
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 209
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 207
Cardiac Magnetic Resonance for Prophylactic Implantable-Cardioverter Defibrillator Therapy in Ischemic Cardiomyopathy: The DERIVATE-ICM International Registry 199
Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: Results from a long-term follow-up multicentre study 198
Troponin in non-ischaemic dilated cardiomyopathy 195
Multimodality Imaging in a Patient With MINOCA and Anomalous Coronary Artery 188
Prevalence and Correlates of Dilated and Non-Dilated Left Ventricular Cardiomyopathy in Transfusion-Dependent Thalassemia: Data from a National, Multicenter, Observational Registry 185
Early or deferred cardiovascular magnetic resonance after ST-segment-elevation myocardial infarction for effective risk stratification 181
Treatment of cardiac transthyretin amyloidosis: an update 179
Pirfenidone is a cardioprotective drug: Mechanisms of action and preclinical evidence 179
Partial Lipodystrophy and LMNA p.R545H Variant 177
Cocaine and methamphetamine use and hospitalization for acute heart failure: Epidemiological evidence from a nationwide dataset 173
Heart & kidney failure: Who's afraid of renin angiotensin system blockade? 170
Management of heart failure with preserved ejection fraction: from neurohormonal antagonists to empagliflozin 169
Post-acute cardiac complications following SARS-CoV-2 infection in partial lipodystrophy due to LMNA gene p.R349W mutation 168
Magnetic Resonance for Differential Diagnosis of Left Ventricular Hypertrophy: Diagnostic and Prognostic Implications 165
Magnetic Resonance to Diagnose Cardiac Amyloidosis: Is it Already Time to Discard Contrast Agents? 147
Echocardiography versus computed tomography and cardiac magnetic resonance for the detection of left heart thrombosis: a systematic review and meta-analysis 146
The Barthel Index in elderly acute heart failure patients. Frailty matters 141
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction 140
The unbearable underreporting of comorbidities in heart failure clinical trials 139
Response to ‘Is the left atrium the key in the amyloid imaging lock?’ 126
Extracellular Volume in Dilated Cardiomyopathy: A New Prognostic Marker on Top of Late Gadolinium Enhancement? 124
European task force reclassification of dilated and non-dilated cardiomyopathies identifies a high arrhythmic-risk overlap phenotype 120
Letter by Aimo et al Regarding Article, "development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies" 113
Prognostic role of updated Lake Louise criteria for the diagnosis of acute myocarditis (ITAMY-mapping study) 98
Photon-Counting Computed Tomography for Tissue Characterization in Patients With a Left Ventricular Hypertrophic Phenotype 95
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 94
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 87
Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies 69
A Novel SCN5A Missense Variant Associated With Familial Non-Dilated Left Ventricular Cardiomyopathy 67
Applications of Artificial Intelligence in Amyloidosis 54
Electrocardiographic abnormalities in patients with cardiomyopathies 53
Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: The role of overlap with arrhythmogenic cardiomyopathy 52
Late gadolinium enhancement dispersion for predicting malignant arrhythmic events in patient with non-ischaemic dilated cardiomyopathy 51
Totale 24.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 117.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 117.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022777 0 0 0 114 32 46 106 183 82 122 18 74
2022/2023689 62 49 31 94 88 99 11 60 105 16 52 22
2023/2024532 41 18 107 57 22 51 48 23 12 14 21 118
2024/20255.058 45 54 208 67 166 214 505 970 327 885 912 705
2025/202611.834 716 1.648 1.334 1.529 1.249 755 1.042 588 733 794 785 661
2026/20271.811 255 358 741 457 0 0 0 0 0 0 0 0
Totale 24.756